EMERGENT BIODEFENSE OPERATIONS LANSING LLC

BIOPORT

prophylactic and therapeutic preparations to prevent and treat infectious diseases and related disorders;BIOPORT;

BIOTHRAX

The drawing is amended to appear as follows: PUBLISH CUT;Pharmaceutical preparations, namely, anthrax vaccine;BIO THRAX;Color is not claimed as a feature of the mark.;

EMERGARD

EMERGENT GUARD; EMERGENT GARD;Injection device for pharmaceuticals, namely, medical auto-injectors; medical syringes; medical auto-injectors, namely, injection devices for administering drugs; automatic-hypodermic syringe injectors;

PROXIGARD

Auto-injectors pre-filled with pharmaceuticals, namely, pralidoxime chloride; pharmaceuticals, namely, pralidoxime; auto-injectors filled with pharmaceutical preparations for use in the treatment of disorders caused by chemical and biological agents;Injection device for pharmaceuticals, namely, medical auto-injectors; medical syringes; medical auto-injectors, namely, infusion and injection devices for administering drugs; nerve agent antidote kits specifically adapted for carrying nerve agent antidote devices, comprised primarily of a case and an auto-injector, and also including a nerve agent antidote; medical devices, namely, nerve agent auto injector kits comprised primarily of pralidoxime auto-injectors; automatic-hypodermic syringe injectors;

PROXIGARD

Auto-injectors pre-filled with pharmaceuticals, namely, pralidoxime chloride; pharmaceuticals, namely, pralidoxime; injectable pharmaceuticals for treatment of disorders caused by chemical and biological agents; injectable pharmaceuticals for treatment of organophosphate poisoning; auto-injectors filled with pharmaceutical preparations for use in the treatment of disorders caused by chemical and biological agents; auto-injectors filled with pharmaceutical preparations for use in the treatment of organophosphate poisoning;Injection device for pharmaceuticals, namely, medical auto-injectors; medical syringes; medical auto-injectors, namely, infusion and injection devices for administering drugs; needle-based injection systems; nerve agent antidote kits specifically adapted for carrying nerve agent antidote devices, comprised primarily of a case and an auto-injector, and also including a nerve agent antidote; automatic-hypodermic syringe injectors;

TEMBEXA

Pharmaceutical preparations for treating viral infections and diseases; antiviral drugs for medical purposes; therapeutic drugs and agents for treating viral infections and diseases; therapeutic formulations for treating viral infections and diseases; antivirals; pharmaceutical preparations in the nature of anti-viral therapies; antiviral pills for pharmaceutical purposes; medical diagnostic reagents for in vivo use; antiviral medicines for human purposes; nutritional supplements;

TROBIGARD

Auto-injectors pre-filled with pharmaceuticals for the prevention and treatment of disorders caused by chemical and biological agents; pharmaceutical preparations and substances for the prevention and treatment of disorders caused by chemical and biological agents;

TROBIGARD

Injection device for pharmaceuticals, namely, medical auto-injectors; medical apparatus, namely, nerve agent antidote delivery kits comprising a pharmaceutical auto-injection device and a protective case; automatic-hypodermic syringe injectors; injection instruments with needles; injection needles; medical fluid injectors; medical syringes;

TROBIGARD

Auto-injectors pre-filled with pharmaceuticals for the prevention and treatment of disorders caused by chemical and biological agents; pharmaceutical preparations and substances for the prevention and treatment of disorders caused by chemical and biological agents;